[1] |
Tahtabasi M, Sahiner F. Tuberculous and non-tuberculous cervical lymphadenopathy incidence and distribution in Somalia from 2016 to 2020: A review of 241 cases. World J Otorhinolaryngol Head Neck Surg, 2022, 8(4):361-369. doi:10.1016/j.wjorl.2021.03.001.
doi: 10.1016/j.wjorl.2021.03.001
URL
|
[2] |
Min KW, Kim DH, Chae SW, et al. Coexistence of metastatic thyroid cancer and tuberculosis in a single neck lymph node: a rare association. Korean J Intern Med, 2018, 33(5):1036-1037. doi:10.3904/kjim.2016.120.
doi: 10.3904/kjim.2016.120
URL
|
[3] |
Oh KH, Woo JS, Cho JG, et al. Efficacy of ultrasound-guided core needle gun biopsy in diagnosing cervical lymphadenopathy. Eur Ann Otorhinolaryngol Head Neck Dis, 2016, 133(6):401-404. doi:10.1016/j.anorl.2016.01.013.
doi: S1879-7296(16)30139-9
pmid: 27592165
|
[4] |
World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
|
[5] |
Rodriguez-Takeuchi SY, RenjifoF ME, Medina FJ. Extrapulmonary Tuberculosis: Pathophysiology and Imaging Findings. Radiographics, 2019, 39(7):2023-2037. doi:10.1148/rg.2019190109.
doi: 10.1148/rg.2019190109
pmid: 31697616
|
[6] |
Deveci HS, Kule M, Kule ZA, et al. Diagnostic challenges in cervical tuberculous lymphadenitis: A review. North Clin Istanb, 2016, 3(2):150-155. doi:10.14744/nci.2016.20982.
doi: 10.14744/nci.2016.20982
pmid: 28058405
|
[7] |
Seo GH, Kim MJ, Seo S, et al. Cancer-specific incidence rates of tuberculosis: A 5-year nationwide population-based study in a country with an intermediate tuberculosis burden. Medicine (Baltimore), 2016, 95(38):e4919. doi:10.1097/md.0000000000004919.
doi: 10.1097/md.0000000000004919
URL
|
[8] |
Yu YH, Liao CC, Hsu WH, et al. Increased lung cancer risk among patients with pulmonary tuberculosis: a population cohort study. J Thorac Oncol, 2011, 6(1):32-37. doi:10.1097/JTO.0b013e3181fb4fcc.
doi: 10.1097/JTO.0b013e3181fb4fcc
URL
|
[9] |
汪训豪, 申磊, 戴希勇. 肺癌合并肺结核52例外科治疗临床分析. 临床外科杂志, 2020, 28(7):647-649. doi:10.3969/j.issn.1005-6483.2020.07.014.
doi: 10.3969/j.issn.1005-6483.2020.07.014
|
[10] |
Varol Y, Varol U, Unlu M, et al. Primary lung cancer coexisting with active pulmonary tuberculosis. Int J Tuberc Lung Dis, 2014, 18(9):1121-1125. doi:10.5588/ijtld.14.0152.
doi: 10.5588/ijtld.14.0152
pmid: 25189563
|
[11] |
Falagas ME, Kouranos VD thanassa ZA, et al. Tuberculosis and malignancy. QJM, 2010, 103(7):461-487. doi:10.1093/qjmed/hcq068.
doi: 10.1093/qjmed/hcq068
pmid: 20504861
|
[12] |
Barwad A, Gowda KK, Dey P. Co-existent of tuberculosis and squamous cell carcinoma in a lymph node diagnosed by fine needle aspiration cytology. Cytopathology, 2012, 23(4):276-277. doi:10.1111/j.1365-2303.2011.00878.x.
doi: 10.1111/j.1365-2303.2011.00878.x
pmid: 21615566
|
[13] |
Caroppo D, Russo D, Merolla F, et al. A rare case of coexistence of metastasis from head and neck squamous cell carcinoma and tuberculosis within a neck lymph node. Diagn Pathol, 2015, 10:197. doi:10.1186/s13000-015-0430-x.
doi: 10.1186/s13000-015-0430-x
pmid: 26510425
|
[14] |
Subramaniam SD, Tuang GJ, Zainal Abidin ZA, et al. Case Report: Metastatic Neck Nodes of Unknown Origin with Concurrent Tuberculous Lymphadenitis. Is Fine Needle Aspiration and Cytology (FNAC) Adequate? Indian J Otolaryngol Head Neck Surg, 2022, 74(Suppl 3):5888-5892. doi:10.1007/s12070-021-02497-w.
doi: 10.1007/s12070-021-02497-w
|
[15] |
李世伟, 卢秀波, 刘洋. 颈部结核性淋巴结炎合并甲状腺乳头状癌淋巴结转移1例报道. 肿瘤基础与临床, 2016, 29(2):173-174. doi:10.3969/j.issn.1673-5412.2016.02.028.
doi: 10.3969/j.issn.1673-5412.2016.02.028
|
[16] |
中华医学会放射学分会头颈学组. 甲状腺结节影像检查流程专家共识. 中华放射学杂志, 2016, 50(12):911-915. doi:10.3760/cma.j.issn.1005-1201.2016.12.003.
doi: 10.3760/cma.j.issn.1005-1201.2016.12.003
|
[17] |
吴刚刚, 边学飞, 周琪, 等. 鼻咽癌患者临床分期的相关因素分析. 温州医科大学学报, 2022, 52(7):577-581. doi:10.3969/j.issn.2095-9400.2022.07.011.
doi: 10.3969/j.issn.2095-9400.2022.07.011
|
[18] |
中华医学会结核病学分会结核病病理学诊断专家共识编写组. 中国结核病病理学诊断专家共识. 中华结核和呼吸杂志, 2017, 40(6):419-425. doi:10.3760/cma.j.issn.1001-0939.2017.06.005.
doi: 10.3760/cma.j.issn.1001-0939.2017.06.005
|
[19] |
唐娟, 刘志艳. 第4版WHO分化型甲状腺癌病理分类及其进展. 外科理论与实践, 2021, 26(6):504-509. doi:10.16139/j.1007-9610.2021.06.009.
doi: 10.16139/j.1007-9610.2021.06.009
|
[20] |
Nair CK, Avaronnan M, Shenoy PK, et al. Impact of active tuberculosis on treatment decisions in cancer. Curr Probl Cancer, 2021, 45(2):100643. doi:10.1016/j.currproblcancer.2020.100643.
doi: 10.1016/j.currproblcancer.2020.100643
URL
|
[21] |
Hirashima T, Tamura Y, Han Y, et al. Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study. BMC Cancer, 2018, 18(1):975. doi:10.1186/s12885-018-4889-1.
doi: 10.1186/s12885-018-4889-1
pmid: 30314434
|